775 related articles for article (PubMed ID: 27276704)
21. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
Kang H; Zhang J; Wang B; Liu M; Zhao J; Yang M; Li Y
Int J Oncol; 2017 Feb; 50(2):545-554. PubMed ID: 28101568
[TBL] [Abstract][Full Text] [Related]
22. NF-κB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder cancer cells.
Zhang Q; Mao Z; Sun J
Gene; 2019 Aug; 710():91-97. PubMed ID: 31002892
[TBL] [Abstract][Full Text] [Related]
23. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.
Li Y; Cao F; Li M; Li P; Yu Y; Xiang L; Xu T; Lei J; Tai YY; Zhu J; Yang B; Jiang Y; Zhang X; Duo L; Chen P; Yu X
J Exp Clin Cancer Res; 2018 Oct; 37(1):259. PubMed ID: 30373678
[TBL] [Abstract][Full Text] [Related]
24. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis.
Wu P; Wu D; Zhao L; Huang L; Chen G; Shen G; Huang J; Chai Y
Oncotarget; 2016 Jun; 7(26):40451-40460. PubMed ID: 27248173
[TBL] [Abstract][Full Text] [Related]
25. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
[TBL] [Abstract][Full Text] [Related]
26. Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages.
Sun L; Chen B; Jiang R; Li J; Wang B
Cell Immunol; 2017 Jan; 311():86-93. PubMed ID: 27825563
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.
Liu L; Ge D; Ma L; Mei J; Liu S; Zhang Q; Ren F; Liao H; Pu Q; Wang T; You Z
J Thorac Oncol; 2012 Jul; 7(7):1091-100. PubMed ID: 22534817
[TBL] [Abstract][Full Text] [Related]
28. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
[TBL] [Abstract][Full Text] [Related]
29. Exposure of tumor-associated macrophages to apoptotic MCF-7 cells promotes breast cancer growth and metastasis.
Zhou N; Zhang Y; Zhang X; Lei Z; Hu R; Li H; Mao Y; Wang X; Irwin DM; Niu G; Tan H
Int J Mol Sci; 2015 May; 16(6):11966-82. PubMed ID: 26016502
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
32. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
34. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells.
Shao XJ; Xiang SF; Chen YQ; Zhang N; Cao J; Zhu H; Yang B; Zhou Q; Ying MD; He QJ
Acta Pharmacol Sin; 2019 Oct; 40(10):1343-1350. PubMed ID: 31296953
[TBL] [Abstract][Full Text] [Related]
36. Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.
Wu ATH; Srivastava P; Yadav VK; Tzeng DTW; Iamsaard S; Su EC; Hsiao M; Liu MC
Toxicol Appl Pharmacol; 2020 Aug; 401():115109. PubMed ID: 32544403
[TBL] [Abstract][Full Text] [Related]
37. HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization.
Sun W; Li S; Tang G; Sun S; Luo Y; Bai R; Han L; Jiang X; Gao Y; Huang Z; Zhang J; Gong Y; Xie C
Cancer Med; 2021 Aug; 10(15):5256-5269. PubMed ID: 34152094
[TBL] [Abstract][Full Text] [Related]
38. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.
Bouillez A; Rajabi H; Jin C; Samur M; Tagde A; Alam M; Hiraki M; Maeda T; Hu X; Adeegbe D; Kharbanda S; Wong KK; Kufe D
Oncogene; 2017 Jul; 36(28):4037-4046. PubMed ID: 28288138
[TBL] [Abstract][Full Text] [Related]
39. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
Zhao C; Setrerrahmane S; Xu H
Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272
[TBL] [Abstract][Full Text] [Related]
40. Macrophages modulate migration and invasion of human tongue squamous cell carcinoma.
Pirilä E; Väyrynen O; Sundquist E; Päkkilä K; Nyberg P; Nurmenniemi S; Pääkkönen V; Pesonen P; Dayan D; Vered M; Uhlin-Hansen L; Salo T
PLoS One; 2015; 10(3):e0120895. PubMed ID: 25811194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]